Background/Objectives: Generous consumption of phytonutrient-rich foods, including blueberries, provides benefits to multiple physiologic and metabolic systems. This study explored the potential that regular, generous blueberry intake could favorably modulate fecal microbiome composition in sedentary older (>60 years) men and women with overweight or obesity (BMI ≥ 25 to 32 kg/m2). Methods: Participants (n = 55) were randomized to daily consumption of either lyophilized blueberry powder (equivalent to 1.5 cups of blueberries) or an indistinguishable placebo powder; both groups participated in weekly supervised exercise classes. Fecal samples were collected at 0 and 12 weeks and frozen. Following this, 16S rRNA gene sequencing was used to profile each participant’s fecal microbiome. Blood biomarkers of cardiometabolic health were measured via nuclear magnetic resonance spectroscopy (NMR) pre- and post-treatment. Results: Comparing the baseline and endpoint results for the blueberry (n = 15) and placebo (n = 19) groups, there were no significant overall compositional differences or differences in the level of diversity in the fecal microbiome. However, in subjects whose diet included blueberry powder, there was a significant enrichment (p = 0.049) in the relative abundance of Coriobacteriales incertae sedis, a taxonomic group of bacteria that facilitates the metabolism of dietary polyphenols. The placebo group exhibited significant reductions in total cholesterol, LDL-C, non-HDL-C, total LDL-P, large LDL-P, and ApoB, while the blueberry group exhibited significant reductions in total HDL-P and ApoA-I after 12 weeks compared to baseline. Conclusions: Generous blueberry consumption may upregulate the ability of the older human gut to utilize dietary polyphenols by altering the fecal microbiome. Longer, larger-scale studies with blueberries or blueberry powder are needed to observe improvements in cardiometabolic risk factors in older adults with overweight or obesity.
This exploratory analysis investigated longitudinal effects of accumulating similar total exercise program volumes at different weekly exercise energy expenditures on cardiorespiratory fitness and metabolic syndrome measures over months to years. In general, adaptations are similar; however, factors other than total energy cost—such as exercise frequency or duration—may modulate longitudinal improvements in cardiorespiratory fitness and skeletal muscle insulin sensitivity over 33 mo of training among sedentary adults with overweight or obesity and dyslipidemia.
24 April 2026 in Infection Control & Hospital Epidemiology
Objective: Racial and ethnic disparities in healthcare-associated infections (HAIs) could have significant implications for hospital-based incentive programs. We sought to quantify racial and ethnic disparities in HAIs across inpatients in the United States. Design: Systematic Review and Meta-Analysis. Methods: Medline, Embase, and Scopus were searched 2008–2022 for English language studies describing reportable HAIs among inpatients and references to race or ethnicity. Studies were excluded if they used an aggregate outcome of “infection,” described a non-acute care setting, or measured a respiratory virus. Meta-analysis was performed using random-effects model on pooled continuous outcomes with 3 or more studies. Results: 39 studies met criteria for inclusion; 23 evaluated surgical site infections (SSI), 6 evaluated hospital-onset Clostridioides difficile infection (HO-CDI), 5 evaluated central line-associated bloodstream infections (CLABSI), and 8 examined other HAIs. There was a high degree of heterogeneity across studies. Meta-analysis was performed for 10 distinct HAI/risk factor combinations. Race and ethnicity were not associated with SSIs (Black vs White OR 1.19, 95% CI 0.95–1.48; Hispanic vs White OR 1.01, 95% CI 0.78–1.31). Hispanic patients had lower risk of HO-CDI relative to White patients (OR 0.80, 95% CI 0.64–0.98). Black (OR 1.36, 95% CI 1.07–1.70) or Hispanic (OR 1.16, 95% CI 1.073–1.249) patients had increased risk of CLABSI compared with White patients. Conclusions: Racial and ethnic disparities were observed in rates of HAIs, specifically for CLABSI and HO-CDI. However, conclusions are limited by the substantial heterogeneity present. Further research characterizing social determinants of health driving these disparities is needed.
1 September 2026 in Open Forum Infectious Diseases
Background: The utility of follow-up blood cultures (FUBCs) in patients with gram-negative bacteremia (GNB) is unsettled. In practice, the use of FUBCs is variable. Understanding practice variation and drivers of FUBC ordering may clarify how clinicians identify patients at high risk for persistent GNB. Methods: We conducted a global survey (21 February 2024 to 9 April 2024) of healthcare workers using 10 hypothetical clinical scenarios to assess FUBC decision-making in GNB. Scenarios varied clinical factors and risk of persistence using the published AIMS scoring tool (Antibiotics, Infection source, Medical conditions, Serratia). The anonymous web-based survey was distributed via listservs, email, and social media. Interrespondent agreement was assessed using Fleiss’ kappa (κ). Mixed-effect logistic regression identified factors associated with FUBC recommendations. Results: Among 864 clinicians from 50 countries, 691 (80%) provided recommendations across 10 scenarios (6910 recommendations). Most were physicians (86.5%) and infectious disease specialists (79.7%). Follow-up blood cultures were frequently recommended, with >50% of clinicians endorsing FUBCs in 6 of 10 scenarios. Overall agreement was fair (κ = 0.26; 95% confidence interval, .10–.43). In adjusted analyses, factors associated with FUBC recommendations included female respondent sex (adjusted odds ratio [aOR] 1.40; P = .042), higher AIMS score (aOR 1.78 per point; P < .0001), older patient age (aOR 2.90; P < .0001), inadequate source control (aOR 4.77; P < .0001), and clinical instability (aOR 114.99; P < .0001). Conclusions: In this survey study, clinicians frequently recommended FUBCs, particularly in clinical vignettes with higher AIMS scores, inadequate source control, and clinical instability. Only fair agreement across risk-stratified scenarios suggests substantial practice variation and supports the need for prospective studies to understand when and in whom FUBCs should be used.